Welcome
Welcome to the Investor Relations section of Vitruvia. This area is dedicated to keeping shareholders and potential investors up to date with relevant information on Vitruvia and its shares.
Press releases
October 8, 2021
Successful certification for the reprocessing of “critical C” devices – Vitruvia Medical now also providing circular systems for highest risk-level medical devices
Vitruvia Medical, which specializes in circular systems for highly complex medical products,…
September 13, 2021
Vitruvia Medical AG reports first-half 2021 results in line with expectations. Board of Directors confirms full-year and 2022 forecasts
Anglikon, September 13, 2021 Vitruvia Medical AG is right on target after the first six months of…
June 30, 2021
Vitruvia Medical’s first Circular Clinic Supply Center for robotic instruments goes live with first customers
Vitruvia is the first European service provider to specialize in circular systems for highly…
Ad-hoc News
May 11, 2021
Vitruvia Medical AG: Listing on Munich Stock Exchange
Effective today, the shares of Vitruvia Medical AG are trading on the Munich Stock Exchange.
Key performance indicatorsVitruvia Medical AG share
Name | Werte |
---|---|
Number of shares | The share capital is CHF 1’839’251.00 and is divided into 1’839’251 registered shares, each with a nominal value of CHF 1.00 |
WKN | A2PDWF |
ISIN | CH0461931419 |
Valor | CH046193141 |
Availability of shares | All registered shares are freely transferable. |
End of fiscal year | December 31 |
Stock exchange | Munich Stock Exchange |
Market segment | General open market |
Initial listing | May 11, 2021 |
Course data
Name | Werte |
---|---|
Current share price (Link to Munich Stock Exchange) | |
52-Week-High | EUR 22,60 |
52-Week-Low | EUR 11,00 |
Dates
Dec 08, 2021 | Participation in Munich Capital Markets Conference
Sep 27, 2021 | Extraordinary General Assembly
Vitruvia Medical AG
Sep 19, 2021 | Publication of half-year financial statements as of June 30, 2021 Vitruvia Medical AG (Group)
Sep 19, 2021 | Publication of half-year report as of
June 30, 2021 Vitruvia Medical AG (Group)
Mar 31, 2021 | Annual General Assembly
Feb 28, 2021 | Publication of annual financial statements
Financial reports
Management Transactions
Your contact

Markus A. Bertschin
President of the Board of Directors
T +41 (0)44 915 33 78
M +41 (0)79 233 26 09
bertschin@vitruvia-med.com
Vitruvia Medical AG
Kesselackerstrasse 18
5611 Anglikon I Switzerland
Newsletter
Do you want to be informed about company news and reports on a regular basis? Then sign up for our newsletter.